Shareholder Update
Provided By GlobeNewswire
Last update: May 30, 2025
May 30, 2025
Biodexa Pharmaceuticals PLC
Shareholder Update
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced a brief update for shareholders.
Read more at globenewswire.com4.35
+0.44 (+11.35%)
Find more stocks in the Stock Screener
BDRX Latest News and Analysis
